Esophageal hypomotility in systemic sclerosis: Close relationship with pulmonary involvement

Annals of Nuclear Medicine

Volumn 15, Issue 2, 2001, Pages 97-101

  Kinuya, Keiko ^a   Nakajima, Kenichi ^b   Kinuya, Seigo ^b   Michigishi, Takatoshi ^b   Tonami, Norihisa ^b   Takehara, Kazuhiko ^b  

^a TONAMI GENERAL HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Antitopoisomerase I antibody; Esophageal hypomotility; Esophageal scintigraphy; Pulmonary involvement; Systemic sclerosis

Indexed keywords

CARBON MONOXIDE; DNA TOPOISOMERASE; ENZYME ANTIBODY; PENTETATE TECHNETIUM TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ESOPHAGUS DISEASE; ESOPHAGUS MOTILITY; FEMALE; HUMAN; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG FIBROSIS; MALE; PRIORITY JOURNAL; SCINTIGRAPHY; SCLERODERMA; SYSTEMIC SCLEROSIS; VITAL CAPACITY;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; DNA TOPOISOMERASES, TYPE I; ESOPHAGEAL MOTILITY DISORDERS; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; RADIOPHARMACEUTICALS; SCLERODERMA, SYSTEMIC; TECHNETIUM TC 99M PENTETATE; VITAL CAPACITY;

EID: 0034993110     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02988598     Document Type: Article

References (33)

1. Scleroderma (systemic sclerosis). Classification, subsets and pathogenesis
2. The gastrointestinal manifestations of scleroderma: Pathogenesis and management
3. Pathologic observations in systemic sclerosis (scleroderma): A study of fifty-eight autopsy cases and fifty-eight matched controls
4. Radionuclide esophageal transit study in detection of esophageal motor dysfunction: Comparison with motility studies (Manometry)
5. Progressive systemic sclerosis: Radionuclide esophageal seintigraphy and manometry
6. Scintigraphic detection of metoclopramide esophageal stimulation in progressive systemic sclerosis
7. Esophageal hypomotility in primary and secondary Raynaud's phenomenon: Comparison of esophageal scintigraphy with manometry
8. Radionuclide transit: A sensitive screening test for esophageal dysfunction
9. Radionuclide transit studies in the detection of esophageal dysfunction
10. Radionuclide esophageal transit in progressive systemic sclerosis
11. Scleroderma (Progressive systemic sclerosis): Prognosis and course based on a personal series of 118 cases
12. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis
13. Serological markers in progressive systemic sclerosis: Clinical correlations
14. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis
15. High titers of autoantibodies to topoisomerase I (Sc170) in sera from scleroderma patients
16. Autoantigenic epitopes on DNA topoisomerase 1
17. Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis
18. Longitudinal change in lung function and respiratory symptoms in progressive systemic sclerosis
19. Organ involvement: Pulmonary
20. Serial changes in scleroderma and idiopathic interstitial lung disease
21. Serial pulmonary function tests in progressive systemic sclerosis
22. Serial pulmonary function in systemic sclerosis
23. Lung function in patients with systemic sclerosis
24. Respiratory disease
25. Normal variation in radionuclide esophageal transit studies
26. Reproducibility of esophageal transit studies: Several single swallows must be performed
27. Multiple swallow test for the quantitative and qualitative evaluation of esophageal motility disorders
28. Esophageal transit scintigraphy
29. Assessment of esophageal abnormalities in progressive systemic sclerosis using radionuclide transit
30. Esophageal dysfunction and radionuclide transit in progressive systemic sclerosis
31. Radionuclide esophageal transit studies in progressive systemic sclerosis: An analysis of longitudinal data
32. Esophageal motility and pulmonary function in progressive systemic sclerosis
33. Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration?